Cadherin-17: A potential biomarker for early detection in pancreatic adenocarcinoma

Table 3 Plasma expression levels of cadherin 17 and carbohydrate antigen 19-9 in paired pre-treatment and post-treatment specimen, stratified by cancer stage

		Healthy	Pre-treatment		Post-treatment
		Controls	Stage I/II	Stage III/IV	Stage I/II	Stage III/IV
CDH17	No. of samples	156	7	21	7	21
	Median (ng/mL)	1.5	7.1	2.0	4.0	2.4
	Range (ng/mL)	0.1-2.9	1.6-11.2	0.6-11.0	0.8-10.2	0.6-32.4
	Mean (ng/mL)	1.5	6.4	3.5	4.7	5.7
CA19-9	No. of samples	30	7	20	7	20
	Median (U/mL)	43	81	167	21	183
	Range (U/mL)	33-66	0-1858	0-195081	0-5540	0-61185
	Mean (U/mL)	45	471	15581	846	3438